Skip to main content

GSA CAPITAL PARTNERS LLP

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in CTMX

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$89,958
-$258,876 QoQ
Shares Held
19,140
-76.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CTMX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CTMX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $89,958 19,140
2025-12-31 $348,834 81,886
2025-09-30 $1,709,757 535,974
2025-06-30 $1,431,936 630,809
2025-03-31 $485,223 762,930
2024-12-31 $40,051 38,885
2024-06-30 $279,493 229,093
2024-03-31 $323,876 148,567
2023-12-31 $161,451 104,162
2023-06-30 $591,970 344,169
2021-09-30 $1,268,153 249,146
2021-03-31 $147,588 19,093
2020-12-31 $208,643 31,854
2020-09-30 $187,869 28,251
2020-06-30 $339,322 40,735
2020-03-31 $471,060 61,416